Lazard Asset Management LLC Legend Biotech Corp Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 9 shares of LEGN stock, worth $332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 25
64.0%
Holding current value
$332
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$412 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$277 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$245 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$211 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$186 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.18B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...